Will Scheibler's questions to Crinetics Pharmaceuticals Inc (CRNX) leadership • Q1 2025
Question
Will Scheibler, on for Joe Schwartz, asked for preliminary thoughts on paltusotine pricing, the potential impact of MFN pricing headlines, and the location of the drug's manufacturing.
Answer
Dr. R. Struthers, CEO, stated that final tablet manufacturing and packaging occur in the U.S., with precursors from Europe and India. Isabel Kalofonos, CCO, added that while not commenting on a specific price, the drug's value proposition is resonating well with payers. She noted no current impact from MFN headlines but confirmed they are monitoring the situation.